GENUS ONCOLOGY, LLC

Organization

CHICAGO, IL, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
- Patent number 11,136,410
- Issue date Oct 5, 2021
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
- Patent number 10,617,773
- Issue date Apr 14, 2020
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
- Patent number 10,059,775
- Issue date Aug 28, 2018
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination anti-human epidermal growth factor receptor 2 (anti-HER...
- Patent number 9,789,156
- Issue date Oct 17, 2017
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination anti-estrogen receptor cancer therapy using MUC1 peptid...
- Patent number 9,572,855
- Issue date Feb 21, 2017
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MUC-1 cytoplasmic domain peptides as inhibitors of cancer
- Patent number 9,546,201
- Issue date Jan 17, 2017
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of inflammation using antagonists of MUC1
- Patent number 9,096,687
- Issue date Aug 4, 2015
- Genus Oncology, LLC.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating MUC1-expressing cancers with combination therapies
- Patent number 9,044,421
- Issue date Jun 2, 2015
- Genus Oncology, LLC
- Donald Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MUC-1 cytoplasmic domain peptides as inhibitors of cancer
- Patent number 8,957,185
- Issue date Feb 17, 2015
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Small molecule inhibitors of MUC1 and methods of identifying the same
- Patent number 8,952,054
- Issue date Feb 10, 2015
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonists of MUC1
- Patent number 8,685,928
- Issue date Apr 1, 2014
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of inflammation using antagonists of MUC1
- Patent number 8,614,186
- Issue date Dec 24, 2013
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MUC-1 cytoplasmic domain peptides as inhibitors of cancer
- Patent number 8,524,669
- Issue date Sep 3, 2013
- Dana-Farber Cancer Institute, Inc.
- Donald W. Kufe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)
- Publication number 20220049014
- Publication date Feb 17, 2022
- Dana-Farber Cancer Institute, Inc.
- Donald W. KUFE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)
- Publication number 20180312605
- Publication date Nov 1, 2018
- Dana-Farber Cancer Institute, Inc.
- Donald W. KUFE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)
- Publication number 20180036441
- Publication date Feb 8, 2018
- Dana-Farber Cancer Institute, Inc.
- Donald W. KUFE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)
- Publication number 20160340442
- Publication date Nov 24, 2016
- Dana-Farber Cancer Institute, Inc.
- Donald W. KUFE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION ANTI-HER2 CANCER THERAPY USING MUC1 PEPTIDES AND CHEMOT...
- Publication number 20160074468
- Publication date Mar 17, 2016
- GENUS ONCOLOGY, LLC
- Donald W. KUFE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION ANTI-ESTROGEN RECEPTOR CANCER THERAPY USING MUC1 PEPTID...
- Publication number 20160058827
- Publication date Mar 3, 2016
- GENUS ONCOLOGY, LLC
- Donald W. KUFE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUC-1 CYTOPLASMIC DOMAIN PEPTIDES AS INHIBITORS OF CANCER
- Publication number 20150152152
- Publication date Jun 4, 2015
- GENUS ONCOLOGY, LLC
- Donald W. KUFE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTS OF MUC1
- Publication number 20140322332
- Publication date Oct 30, 2014
- GENUS ONCOLOGY, LLC
- Donald W. KUFE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF INFLAMMATION USING ANTAGONISTS OF MUC1
- Publication number 20140187494
- Publication date Jul 3, 2014
- GENUS ONCOLOGY, LLC
- Donald W. KUFE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 1

Research Projects

Information Research Project
Human MUC1 MUC1 Oncoprotein: Development of MUC1-decoy soluble rece...
- Application id 7534921
- Award notice date Sep 9, 2008

GENUS ONCOLOGY, LLC

Organization

Patents Grantslast 30 patents

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

Combination anti-human epidermal growth factor receptor 2 (anti-HER...

Combination anti-estrogen receptor cancer therapy using MUC1 peptid...

MUC-1 cytoplasmic domain peptides as inhibitors of cancer

Inhibition of inflammation using antagonists of MUC1

Treating MUC1-expressing cancers with combination therapies

MUC-1 cytoplasmic domain peptides as inhibitors of cancer

Small molecule inhibitors of MUC1 and methods of identifying the same

Antagonists of MUC1

Inhibition of inflammation using antagonists of MUC1

MUC-1 cytoplasmic domain peptides as inhibitors of cancer

Patents Applicationslast 30 patents

ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)

ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)

ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)

ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)

COMBINATION ANTI-HER2 CANCER THERAPY USING MUC1 PEPTIDES AND CHEMOT...

COMBINATION ANTI-ESTROGEN RECEPTOR CANCER THERAPY USING MUC1 PEPTID...

MUC-1 CYTOPLASMIC DOMAIN PEPTIDES AS INHIBITORS OF CANCER

ANTAGONISTS OF MUC1

INHIBITION OF INFLAMMATION USING ANTAGONISTS OF MUC1

NIH Research Projectlast 12 months

Research Projects

Human MUC1 MUC1 Oncoprotein: Development of MUC1-decoy soluble rece...